MEDP Medpace Holdings, Inc.

Nasdaq medpace.com


$ 585.05 $ 4.04 (0.7 %)    

Wednesday, 29-Oct-2025 15:59:58 EDT
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 584.57
$ 585.24
$ 575.45 x 2
$ 636.00 x 10
$ 578.50 - $ 592.38
$ 250.05 - $ 625.00
264,815
na
16.47B
$ 1.44
$ 38.03
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-23-2025 09-30-2025 10-Q
2 07-22-2025 06-30-2025 10-Q
3 04-22-2025 03-31-2025 10-Q
4 02-11-2025 12-31-2024 10-K
5 10-22-2024 09-30-2024 10-Q
6 07-23-2024 06-30-2024 10-Q
7 04-23-2024 03-31-2024 10-Q
8 02-13-2024 12-31-2023 10-K
9 10-24-2023 09-30-2023 10-Q
10 07-25-2023 06-30-2023 10-Q
11 04-25-2023 03-31-2023 10-Q
12 02-14-2023 12-31-2022 10-K
13 10-25-2022 09-30-2022 10-Q
14 07-26-2022 06-30-2022 10-Q
15 04-26-2022 03-31-2022 10-Q
16 02-15-2022 12-31-2021 10-K
17 10-26-2021 09-30-2021 10-Q
18 07-27-2021 06-30-2021 10-Q
19 04-27-2021 03-31-2021 10-Q
20 02-16-2021 12-31-2020 10-K
21 10-27-2020 09-30-2020 10-Q
22 07-28-2020 06-30-2020 10-Q
23 04-29-2020 03-31-2020 10-Q
24 02-25-2020 12-31-2019 10-K
25 10-29-2019 09-30-2019 10-Q
26 07-30-2019 06-30-2019 10-Q
27 04-30-2019 03-31-2019 10-Q
28 02-26-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 07-31-2018 06-30-2018 10-Q
31 05-01-2018 03-31-2018 10-Q
32 02-27-2018 12-31-2017 10-K
33 10-31-2017 09-30-2017 10-Q
34 08-01-2017 06-30-2017 10-Q
35 05-02-2017 03-31-2017 10-Q
36 02-28-2017 12-31-2016 10-K
37 11-03-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-sell-on-medpace-hldgs-raises-price-target-to-462

TD Cowen analyst Charles Rhyee maintains Medpace Hldgs (NASDAQ:MEDP) with a Sell and raises the price target from $356 to $462.

 barclays-maintains-underweight-on-medpace-hldgs-raises-price-target-to-485

Barclays analyst Luke Sergott maintains Medpace Hldgs (NASDAQ:MEDP) with a Underweight and raises the price target from $425...

 mizuho-maintains-outperform-on-medpace-hldgs-raises-price-target-to-655

Mizuho analyst Ann Hynes maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $575 to $655.

 medpaces-q3-earnings-beat-reflects-robust-growth-and-large-new-wins

Medpace shares climb as Q3 earnings and revenue top estimates, driven by strong bookings, rising backlog, and an upbeat 2025 gu...

 medpace-hldgs-raises-fy2025-gaap-eps-guidance-from-1376-1453-to-1460-1486-vs-1407-est-raises-fy2025-sales-guidance-from-2420b-2520b-to-2480b-2530b-vs-2464b-est

Medpace Hldgs (NASDAQ:MEDP) raises FY2025 GAAP EPS guidance from $13.76-$14.53 to $14.60-$14.86 vs $14.07 analyst estimate. Rai...

 medpace-hldgs-q3-eps-386-beats-352-estimate-sales-659903m-beat-640997m-estimate

Medpace Hldgs (NASDAQ:MEDP) reported quarterly earnings of $3.86 per share which beat the analyst consensus estimate of $3.52 b...

 preview-medpace-hldgss-earnings
Preview: Medpace Hldgs's Earnings
10/21/2025 15:03:25

 mizuho-maintains-outperform-on-medpace-hldgs-raises-price-target-to-575

Mizuho analyst Ann Hynes maintains Medpace Hldgs (NASDAQ:MEDP) with a Outperform and raises the price target from $510 to $575.

 barclays-downgrades-medpace-hldgs-to-underweight-lowers-price-target-to-425

Barclays analyst Luke Sergott downgrades Medpace Hldgs (NASDAQ:MEDP) from Equal-Weight to Underweight and lowers the price t...

 jefferies-maintains-hold-on-medpace-hldgs-raises-price-target-to-450

Jefferies analyst David Windley maintains Medpace Hldgs (NASDAQ:MEDP) with a Hold and raises the price target from $400 to $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION